Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June

Retrieved on: 2024-04-26 15:18:18

Tags for this article:

Specialty drugs

Accredo

Biopharmaceuticals

Immunosuppressants

Monoclonal antibodies

Click the tags to see associated articles and topics

Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June. View article details on hiswai:

Excerpt

... platforms and solutions ... Evernorth Acquires Bright.md Technology Platform, Enhances MDLIVE's Virtual Care Experience for Patients and Clinicians.

Article found on: www.prnewswire.com

View Original Article